Financhill
Sell
45

BDTX Quote, Financials, Valuation and Earnings

Last price:
$2.20
Seasonality move :
9.89%
Day range:
$2.12 - $2.35
52-week range:
$2.09 - $7.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.27x
Volume:
481.8K
Avg. volume:
481.2K
1-year change:
-26.26%
Market cap:
$123.9M
Revenue:
--
EPS (TTM):
-$1.33

Earnings Data

Next earnings date for BDTX
Mar 12
2025
Most recent earnings per share
-$0.28
Beat by $0.08
(Nov 5/2024)
Consensus Estimate
-$0.36
(Nov 5/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BDTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/12/2025 Q4 -- -- -- -$0.31 --
11/05/2024 Q3 -- -- -$0.28 -$0.36 $0.08
08/06/2024 Q2 -- -- -$0.36 -$0.39 $0.03
05/09/2024 Q1 -- -- -$0.35 -$0.43 $0.08
03/12/2024 Q4 -- -- -$0.34 -$0.46 $0.12
11/06/2023 Q3 -- -- -$0.45 -$0.49 $0.04
08/11/2023 Q2 -- -- -$0.52 -$0.52 $0.00
05/09/2023 Q1 -- -- -$0.57 -$0.61 $0.04
03/17/2023 Q4 -- -- -$0.59 -$0.61 $0.02
11/08/2022 Q3 -- -- -$0.60 -$0.62 $0.02
08/09/2022 Q2 -- -- -$0.63 -$0.67 $0.04
05/11/2022 Q1 -- -- -$0.70 -$0.74 $0.04
03/17/2022 Q4 -- -- -$0.71 -$0.98 $0.27
11/08/2021 Q3 -- -- -$0.97 -$0.95 -$0.02
08/12/2021 Q2 -- -- -$0.95 -$0.88 -$0.07
05/07/2021 Q1 -- -- -$0.84 -$0.65 -$0.19
03/25/2021 Q4 -- -- -$0.63 -$0.61 -$0.02
11/10/2020 Q3 -- -- -$0.50 -$0.50 $0.00
08/11/2020 Q2 -- -- -$0.41 -$0.39 -$0.02
05/12/2020 Q1 -- -- -$0.51 -$0.49 -$0.02
03/24/2020 Q4 -- -- -$0.30 -- --
09/30/2019 Q3 -- -- -$0.66 -- --
06/30/2019 Q2 -- -- -$0.88 -- --
03/31/2019 Q1 -- -- -$0.27 -- --
12/31/2018 Q4 -- -- -$0.22 -- --

Black Diamond Therapeutics Earnings Questions

  • How Much did Black Diamond Therapeutics Generate in Revenue Last Quarter?

    Black Diamond Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Black Diamond Therapeutics Beat Earnings Last Quarter?

    Black Diamond Therapeutics announced earnings per share of -$0.28 which represents a beat of analyst forecast a -$0.36 per share.

  • Is Black Diamond Therapeutics Profitable?

    Black Diamond Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Black Diamond Therapeutics EPS Next Year?

    Black Diamond Therapeutics's earnings are forecast to decrease from -$1.88 per share to -$1.93 per share next year representing a decrease of -32.54%.

  • When is Black Diamond Therapeutics's Earnings Date?

    Black Diamond Therapeutics's next earnings date is March 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Uber Stock a Buy on the Dip?
Is Uber Stock a Buy on the Dip?

Shares of Uber Technologies (NYSE:UBER) have been fading fast in…

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 115x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
50
LMND alert for Dec 28

Lemonade [LMND] is down 10.69% over the past day.

Sell
50
TSLL alert for Dec 28

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.

Buy
63
SMLR alert for Dec 28

Semler Scientific [SMLR] is down 9.65% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock